You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Methyltransferase inhibitor

Showing 1 - 25 of 7,476
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022

Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL, Leukemia Cutis, Recurrent Acute Myeloid Leukemia Trial in New York

Completed
Has Results
  • Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 11, 2021

Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 27, 2022

Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
Jan 27, 2023

Advanced MTAP-null Solid Tumors Trial in Worldwide (AMG 193, Docetaxel)

Recruiting
  • Advanced MTAP-null Solid Tumors
  • Duarte, California
  • +17 more
Aug 11, 2022

Glioblastoma, Adult Trial in United States (Paxalisib (GDC-0084))

Active, not recruiting
  • Glioblastoma, Adult
  • Paxalisib (GDC-0084)
  • Los Angeles, California
  • +5 more
Aug 16, 2022

Immunotherapy, Refractory Leukemia, Relapsed Adult AML Trial in Suzhou (Visilizumab)

Recruiting
  • Immunotherapy
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 2, 2021

Tumors Trial run by the National Cancer Institute (NCI) (FdCyd + THU)

Completed
  • Neoplasms
  • FdCyd + THU
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)

Recruiting
  • Neoplasms
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

Active, not recruiting
  • Malignant Rhabdoid Tumors (MRT)
  • +10 more
  • San Francisco, California
  • +31 more
Jan 17, 2023

MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat

Active, not recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Neoplasm
  • Azacitidine Subcutaneous Injection or Intravenous Infusion
  • +2 more
  • Miami, Florida
  • +4 more
Jun 20, 2022

Advanced Solid Tumor, Recurrent Glioma, CNS Lymphoma Trial in United States (PRT811)

Active, not recruiting
  • Advanced Solid Tumor
  • Recurrent Glioma
  • Denver, Colorado
  • +9 more
Dec 16, 2022

Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

Temporarily not available
  • Epithelioid Sarcoma (Ex-US Only)
  • +19 more
  • (no location specified)
Oct 17, 2022

Acute Myeloid Leukemia Trial (Camrelizumab(SHR-1210), Decitabine)

Unknown status
  • Acute Myeloid Leukemia
  • (no location specified)
Apr 16, 2020

Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (JNJ-75276617)

Recruiting
  • Acute Leukemias
  • +2 more
  • Duarte, California
  • +28 more
Jan 27, 2023

Relapsed/Refractory Non-Hodgkin Lymphoma, Advanced Solid Tumors Trial in Beijing (Chidamide, Decitabine, Immune checkpoint

Recruiting
  • Relapsed/Refractory Non-Hodgkin Lymphoma
  • Advanced Solid Tumors
  • Beijing, Beijing, China
    Biotherapeutic Department, Chinese PLA General Hospital
Apr 8, 2022

Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Decision Making, Executive Function, Dopamine Trial in Berkeley (Tolcapone 200 MG, Functional Magnetic Resonance Imaging (fMRI))

Recruiting
  • Decision Making
  • +2 more
  • Tolcapone 200 MG
  • Functional Magnetic Resonance Imaging (fMRI)
  • Berkeley, California
    University of California, Berkeley
Jan 13, 2022

Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

Active, not recruiting
  • Glioblastoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 30, 2023

Rhabdoid Tumors, INI1-negative Tumors, Synovial Sarcoma Trial in Worldwide (Tazemetostat)

Completed
  • Rhabdoid Tumors
  • +3 more
  • Los Angeles, California
  • +34 more
Dec 23, 2021

MDS/MPN Trial in Nashville (ASTX727, Itacitinib)

Recruiting
  • MDS/MPN
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jun 20, 2022

Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

Suspended
  • Solid Tumor
  • ARID1A Gene Mutation
  • Greenville, South Carolina
    Prisma Health Cancer Institute
Jan 10, 2023

Acute Myeloid Leukemia, MDS Trial in China (TQB2928 Injection + Azacitidine for injection)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • TQB2928 Injection + Azacitidine for injection
  • Beijing, Beijing, China
  • +8 more
Aug 22, 2023

Leukemia, Myeloid, Acute Trial in Worldwide (JNJ-75276617, Venetoclax (VEN), Azacitidine (AZA))

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +30 more
Aug 11, 2022

Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati

Recruiting
  • Relapsed/Refractory Leukemias
  • +4 more
  • Kansas City, Missouri
  • +1 more
Jul 18, 2022